Attached files

file filename
10-K - 10-K - CytoDyn Inc.cydy-20210531x10k.htm
EX-32 - EX-32 - CytoDyn Inc.cydy-20210531xex32.htm
EX-31.2 - EX-31.2 - CytoDyn Inc.cydy-20210531xex31d2.htm
EX-31.1 - EX-31.1 - CytoDyn Inc.cydy-20210531xex31d1.htm
EX-23 - EX-23 - CytoDyn Inc.cydy-20210531xex23.htm
EX-21 - EX-21 - CytoDyn Inc.cydy-20210531xex21.htm
EX-10.68 - EX-10.68 - CytoDyn Inc.cydy-20210531xex10d68.htm
EX-10.10 - EX-10.10 - CytoDyn Inc.cydy-20210531xex10d10.htm
EX-10.9 - EX-10.9 - CytoDyn Inc.cydy-20210531xex10d9.htm
EX-10.8 - EX-10.8 - CytoDyn Inc.cydy-20210531xex10d8.htm
EX-10.7 - EX-10.7 - CytoDyn Inc.cydy-20210531xex10d7.htm
EX-4.1 - EX-4.1 - CytoDyn Inc.cydy-20210531xex4d1.htm

Exhibit 24

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Nader Z. Pourhassan and Antonio Migliarese, and each of them, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, to sign the registrant’s Annual Report on Form 10 K for the fiscal year ended May 31, 2021, including any and all amendments and supplements thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully and to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Signatures

Title

Date

/s/ Nader Z. Pourhassan

 

Director, President and Chief Executive Officer

July 29, 2021

Nader Z. Pourhassan, Ph.D.

(Principal Executive Officer)

/s/ Antonio Migliarese

 

Chief Financial Officer and Treasurer

July 30, 2021

Antonio Migliarese

(Principal Financial Officer and Principal Accounting Officer)

/s/ Scott A. Kelly

 

Director, Chairman

July 29, 2021

Scott A. Kelly, M.D.

 

/s/ Gordon A. Gardiner

 

Director

July 29, 2021

Gordon A. Gardiner

 

/s/ Jordan G. Naydenov

 

Director

July 29, 2021

Jordan G. Naydenov

 

/s/ Samir R. Patel

 

Director

July 29, 2021

Samir R. Patel, M.D.

 

/s/ Alan P. Timmins

 

Director

July 29, 2021

Alan P. Timmins